CMS’s 2027 CLFS Reset Draws a Line Between Commodity Labs and Protected Diagnostics

CMS’s 2027 CLFS reset is compressing commodity lab reimbursement while shielding tests with specific coverage and payment pathways, making reimbursement design a competitive moat.

• •Nearly 1,200 tests face lower Medicare payment; about 775 codes hit the 15% annual cut cap.
• •Commodity, fee-schedule-exposed labs are most vulnerable to reimbursement compression.
• •Protected diagnostics with PLA or MolDX coverage are gaining insulation from broad cuts.
• •Evidence of subgroup benefit and management impact is driving payer acceptance.
• •Reimbursement structure is becoming a strategic differentiator, not just an admin detail.